Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609986 · ClinicalTrials.gov registry record · NA
IV Insulin Protocol in Diabetes and Renal Transplantation
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT00609986 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 104 participants.
The verdict
NCT00609986, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
Purpose: The purpose of this study is to provide tight blood sugar control using insulin given through the veins at the time of kidney transplantation and up to 3 days after surgery. After release from the hospital, the patient will control blood sugar with subcutaneous insulin injections or pills. With this approach, outcomes should improve for diabetic transplant patients such as longer life of the new kidney, fewer hospital readmissions, decreased associated infections, and other advantages. Hypothesis: It is hypothesized that intensive glycemic control will lead to better clinical and biochemical outcomes and improved long-term graft survival.
Interventions
- DRUG insulin
- DRUG NPH Insulin or glargine insulin and aspartame insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609986
The ClinicalTrials.gov registry entry for NCT00609986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insulin is the first listed.
NCT00609986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609986 about?
NCT00609986 is a clinical study titled "IV Insulin Protocol in Diabetes and Renal Transplantation". Purpose: The purpose of this study is to provide tight blood sugar control using insulin given through the veins at the time of kidney transplantation and up to 3 days after surgery. After release from the hospital, the patient will control blood sugar with subcutaneous insulin injections or pills. ...
What is the current status of trial NCT00609986?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2007-07. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00609986?
The interventions under investigation include: insulin (DRUG), NPH Insulin or glargine insulin and aspartame insulin (DRUG).
Who is sponsoring clinical trial NCT00609986?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.